Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RUVBL1/2 ATPase-IN-1 is an effective RUVBL1/2 ATPase inhibitor with IC50 values of 6.0 and 7.7 μM, respectively. RUVBL1/2 ATPase-IN-1 can be used in cancer disease studies.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 376.00 | |
5 mg | In stock | $ 882.00 | |
10 mg | In stock | $ 1,230.00 | |
25 mg | In stock | $ 1,830.00 | |
50 mg | In stock | $ 2,460.00 | |
100 mg | In stock | $ 3,320.00 |
Description | RUVBL1/2 ATPase-IN-1 is an effective RUVBL1/2 ATPase inhibitor with IC50 values of 6.0 and 7.7 μM, respectively. RUVBL1/2 ATPase-IN-1 can be used in cancer disease studies. |
Targets&IC50 | RUVBL1:6.0 μM, RUVBL2:7.7 μM |
Molecular Weight | 507.55 |
Formula | C28H28F3N5O |
CAS No. | 423128-55-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 8 mg/mL (15.76 mM), Sonification and heating to 60℃ are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RUVBL1/2 ATPase-IN-1 423128-55-6 Others RUVBL1/2 ATPaseIN1 inhibit Inhibitor selective RUVBL1/2 ATPase IN 1 cancer RUVBL1 AAA ATPases RUVBL2 inhibitor